Hatano Taku, Funayama Manabu, Kubo Shin-Ichiro, Mata Ignacio F, Oji Yutaka, Mori Akio, Zabetian Cyrus P, Waldherr Sarah M, Yoshino Hiroyo, Oyama Genko, Shimo Yasushi, Fujimoto Ken-Ichi, Oshima Hirokazu, Kunii Yasuto, Yabe Hirooki, Mizuno Yoshikuni, Hattori Nobutaka
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan; Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Neurobiol Aging. 2014 Nov;35(11):2656.e17-2656.e23. doi: 10.1016/j.neurobiolaging.2014.05.025. Epub 2014 Jun 2.
Leucine-rich repeat kinase 2 (LRRK2) is a causative gene of autosomal dominant familial Parkinson's disease (PD). We screened for LRRK2 mutations in 3 frequently reported exons (31, 41, and 48) in our cohort of 871 Japanese patients with PD (430 with sporadic PD and 441 probands with familial PD). Direct sequencing analysis of LRRK2 revealed 1 proband (0.11%) with a p.R1441G mutation, identified for the first time in Asian countries, besides frequently reported substitutions including, the p.G2019S mutation (0.11%) and p.G2385R variant (11.37%). Several studies have suggested that the LRRK2 p.R1441G mutation, which is highly prevalent in the Basque country, is extremely rare outside of northern Spain. Further analysis of family members of the proband with the p.R1441G mutation revealed that her mother and first cousin shared the same mutation and parkinsonism. Haplotype analysis revealed a different haplotype from that of the original Spanish families. Our patients demonstrated levodopa-responsive parkinsonism with intrafamilial clinical heterogeneity. This is the first report of familial PD because of the LRRK2 p.R1441G mutation in Asia.
富含亮氨酸重复激酶2(LRRK2)是常染色体显性遗传性帕金森病(PD)的致病基因。我们在871名日本PD患者(430例散发性PD患者和441例家族性PD先证者)队列中,对3个频繁报道的外显子(31、41和48)进行了LRRK2突变筛查。LRRK2的直接测序分析显示,有1名先证者(0.11%)存在p.R1441G突变,这是亚洲国家首次发现,此外还有一些常见的替代突变,包括p.G2019S突变(0.11%)和p.G2385R变异(11.37%)。多项研究表明,LRRK2 p.R1441G突变在巴斯克地区非常普遍,在西班牙北部以外地区极为罕见。对携带p.R1441G突变的先证者家庭成员的进一步分析显示,她的母亲和一级表亲都有相同的突变和帕金森症。单倍型分析显示,其单倍型与最初的西班牙家族不同。我们的患者表现出左旋多巴反应性帕金森症,且家族内存在临床异质性。这是亚洲地区关于LRRK2 p.R1441G突变导致家族性PD的首次报道。